Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2026-02-03 00:00:00 ET · period of report 2026-01-30 · accession 0001193125-26-034628 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-01-30 | HRTX | Cusack Thomas | Dir | A - Grant | $0.00 | +54.0K | 54.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-30 | A | A | 53,960 | $0.00 | 53,960 | D | — | — | (F1) The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock. |